January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Lung Cancer's Paradox: Never-Smokers Outlive Smokers?

New research challenges conventional wisdom as never-smokers with NSCLC present with more advanced disease but achieve median survival of 6.6 years versus 3.9 years in smokers, upending traditional prognostic assumptions.

Conexiant

January 15, 2025

Trial Ends Early Over Safety Concern

Keros Therapeutics halts testing of experimental blood pressure treatment due to safety concerns during mid-stage trial, citing excess fluid build up around the heart in patients with pulmonary arterial hypertension.

Reuters

January 15, 2025

Unburned Homes Post-Wildfire Pose Risks

People with smoke or ash damaged homes reported more physical health symptoms six months postfire than those in nondamaged homes.

Reuters

January 15, 2025

CMR-PCWP Correlates with Heart Failure Biomarkers

In HFrEF patients, cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure "correlates with clinical and ultrasound markers of congestion," demonstrates potential as a non-invasive alternative to traditional pressure measurements.

Conexiant

January 13, 2025

Transcatheter Valve Replacement: Key 1-Year Outcomes

Transcatheter tricuspid-valve replacement reduced tricuspid regurgitation to a level that is mild or less in 95% of patients, with associated improvements in quality of life, functional capacity, and survival compared to medical therapy.

Conexiant

January 09, 2025

Impaired Lung Function Linked to Gout

Patients with impaired lung function face up to double the gout prevalence—explore the inflammatory pathways driving this connection.

Conexiant

December 13, 2024

New Vaccine Prevents Severe RSV Illness

A recent study showed the new vaccine was more than 90% effective in the prevention of hospitalizations and emergency department visits due to RSV among those 60 years old or older.

Conexiant

November 13, 2024

Is COPD Set to Affect 600M Globally?

GOLD 2025 highlights new pathways and advanced COPD therapies like ensifentrine and dupilumab to reduce exacerbations and address emerging COPD phenotypes.

Conexiant